Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-28

FDA Approved: TAFLUPROST — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approves Sandoz's Tafluprost as an original application (ANDA) for generic tafluprost indicated to reduce intraocular pressure in open-angle glaucoma and oc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tafluprost (tafluprost)

Snippet

ORIG AP for TAFLUPROST (TAFLUPROST)